EN
TR
Colchicine treatment in recurrent subacute thyroiditis after Covid-19 and mRNA vaccination
Öz
Subacute thyroiditis (SAT) is an inflammatory disease of the thyroid gland. It usually develops after a viral upper respiratory infection. It is often self-limited, but about 20% of cases are refractory to treatment with steroids. Steroid therapy is the first line of treatment for recurrent episodes of SAT. This letter reports that colchicine may be beneficial in two cases of recurrent SAT after covid-19 infection and mRNA vaccination.
Anahtar Kelimeler
Kaynakça
- 1.Brancatella, A., Ricci, D., Viola, N., Sgrò, D., Santini, F., & Latrofa, F. (2020). Subacute Thyroiditis After Sars-COV-2 Infection. The Journal of clinical endocrinology and metabolism, 105(7), dgaa276. https://doi.org/10.1210/clinem/dgaa276
- 2.İremli, B. G., Şendur, S. N., & Ünlütürk, U. (2021). Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine: Postvaccination ASIA Syndrome. The Journal of clinical endocrinology and metabolism, 106(9), 2600–2605. https://doi.org/10.1210/clinem/dgab373
- 3.Tian, Z., Su, Y., Zhang, M., Zhang, X., & Guan, Q. (2020). Successful Management of Recurrent Subacute Thyroiditis by Adding Colchicine to Glucocorticoid Treatment: A Case Series Study. Hormone and metabolic research, 52(10), 712–717. https://doi.org/10.1055/a-1148-2260
- 4.Bahçecioğlu, A. B., & Erdoğan, M. F. (2024). Colchicine as a Steroid-Sparing Agent in Relapsing and Steroid-Dependent Subacute Thyroiditis: Preliminary Observations. Thyroid : official journal of the American Thyroid Association, 34(11), 1444–1446
Ayrıntılar
Birincil Dil
İngilizce
Konular
Endokrinoloji
Bölüm
Mektup
Yayımlanma Tarihi
21 Nisan 2025
Gönderilme Tarihi
12 Mart 2025
Kabul Tarihi
27 Mart 2025
Yayımlandığı Sayı
Yıl 2025 Cilt: 1 Sayı: 1
APA
Oğuz, A., & Şahin, M. (2025). Colchicine treatment in recurrent subacute thyroiditis after Covid-19 and mRNA vaccination. Kahramanmaraş Sütçü İmam Üniversitesi Sağlık Bilimleri Dergisi, 1(1), 1-3. https://izlik.org/JA93JG59GR
AMA
1.Oğuz A, Şahin M. Colchicine treatment in recurrent subacute thyroiditis after Covid-19 and mRNA vaccination. KSÜ Sağlık Bilimleri Dergisi. 2025;1(1):1-3. https://izlik.org/JA93JG59GR
Chicago
Oğuz, Ayten, ve Murat Şahin. 2025. “Colchicine treatment in recurrent subacute thyroiditis after Covid-19 and mRNA vaccination”. Kahramanmaraş Sütçü İmam Üniversitesi Sağlık Bilimleri Dergisi 1 (1): 1-3. https://izlik.org/JA93JG59GR.
EndNote
Oğuz A, Şahin M (01 Nisan 2025) Colchicine treatment in recurrent subacute thyroiditis after Covid-19 and mRNA vaccination. Kahramanmaraş Sütçü İmam Üniversitesi Sağlık Bilimleri Dergisi 1 1 1–3.
IEEE
[1]A. Oğuz ve M. Şahin, “Colchicine treatment in recurrent subacute thyroiditis after Covid-19 and mRNA vaccination”, KSÜ Sağlık Bilimleri Dergisi, c. 1, sy 1, ss. 1–3, Nis. 2025, [çevrimiçi]. Erişim adresi: https://izlik.org/JA93JG59GR
ISNAD
Oğuz, Ayten - Şahin, Murat. “Colchicine treatment in recurrent subacute thyroiditis after Covid-19 and mRNA vaccination”. Kahramanmaraş Sütçü İmam Üniversitesi Sağlık Bilimleri Dergisi 1/1 (01 Nisan 2025): 1-3. https://izlik.org/JA93JG59GR.
JAMA
1.Oğuz A, Şahin M. Colchicine treatment in recurrent subacute thyroiditis after Covid-19 and mRNA vaccination. KSÜ Sağlık Bilimleri Dergisi. 2025;1:1–3.
MLA
Oğuz, Ayten, ve Murat Şahin. “Colchicine treatment in recurrent subacute thyroiditis after Covid-19 and mRNA vaccination”. Kahramanmaraş Sütçü İmam Üniversitesi Sağlık Bilimleri Dergisi, c. 1, sy 1, Nisan 2025, ss. 1-3, https://izlik.org/JA93JG59GR.
Vancouver
1.Ayten Oğuz, Murat Şahin. Colchicine treatment in recurrent subacute thyroiditis after Covid-19 and mRNA vaccination. KSÜ Sağlık Bilimleri Dergisi [Internet]. 01 Nisan 2025;1(1):1-3. Erişim adresi: https://izlik.org/JA93JG59GR